已收盘 08-01 16:00:00 美东时间
-0.080
-2.48%
The latest update is out from Lipocine ( ($LPCN) ). On July 9, 2025, Lipocine h...
07-09 23:28
Lipocine ( ($LPCN) ) just unveiled an announcement. Lipocine has updated its co...
07-02 23:48
An announcement from Lipocine ( ($LPCN) ) is now available. On June 26, 2025, L...
06-26 21:57
Lipocine ( ($LPCN) ) has provided an update. Lipocine Inc. announced it will ho...
06-24 02:57
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Metsera(MTSR)"买入"评级,目标价从56美元升至62美元</p> <p>• 摩根大通:维持Avidity Biosciences(RNA)"超配"评级,目标价从57美元升至59美元</
06-11 09:43
Lipocine ( ($LPCN) ) has shared an update. On June 9, 2025, Lipocine announced ...
06-09 18:28
New Drug Submission filed by Lipocine's licensing partner Verity PharmaOver 700,000 total prescriptions written annually for testosterone replacement therapy (TRT) in Canada, representing large commercial opportunity
06-09 18:25
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持Cogent Biosciences(COGT)"超配"评级,目标价从21美元升至25美元</p> <p>• Chardan Capital:维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
HC Wainwright & Co. analyst Yi Chen assumes Lipocine (NASDAQ:LPCN) with a Buy rating and announces Price Target of $8.
05-29 22:46
The latest update is out from Lipocine ( ($LPCN) ). Lipocine Inc. announced tha...
05-22 21:57